Related Experiment Videos
[Usefulness of CT-guided RFA for hepatocellular carcinoma]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 16, 2001
Summary
Computed tomography (CT)-guided radiofrequency ablation (RFA) offers a viable alternative for treating hepatocellular carcinoma (HCC) when ultrasound (US) guidance is challenging due to tumor location. This method proved effective for most patients, with manageable complications.
Area of Science:
- Interventional Radiology
- Oncology
- Medical Imaging
Context:
- Radiofrequency ablation (RFA) is a common treatment for hepatocellular carcinoma (HCC).
- Ultrasound (US)-guided puncture is the standard method for RFA in HCC.
- Tumor location can impede US detection, limiting treatment accessibility.
Purpose:
- To evaluate the utility and safety of CT-guided RFA for HCC treatment.
- To assess the effectiveness of CT-guided RFA in cases where US guidance is difficult.
Summary:
- CT-guided RFA was performed on 27 HCC nodules in 21 patients between July 1999 and June 2001.
- The procedure was successful in most patients, with transient increases in liver enzymes and minor complications like subcutaneous emphysema and pleural effusion being effectively managed.
- US-guided puncture was particularly beneficial for subdiaphragmatic tumors that were difficult to visualize with US.
Impact:
- CT-guided RFA expands treatment options for HCC patients, especially those with challenging tumor locations.
- Demonstrates the feasibility and safety of CT-guided RFA as an alternative to US-guided RFA.
- Highlights the importance of advanced imaging guidance in optimizing oncological interventions.